Investment Summary

SHS Invests In AMW

On September 8, 2014, private equity firm SHS invested in medical products company AMW

Investment Highlights
  • This is SHS’s 6th transaction in the Medical Products sector.
  • This is SHS’s 9th transaction in Germany.

Investment Summary
Date 2014-09-08
Target AMW
Sector Medical Products
Investor(s) SHS
Deal Type Growth Capital

Target

AMW

Warngau, Germany
website
AMW is a specialty pharmaceutical company that develops and manufactures active and passive transdermal patches, biodegradable subcutaneous implants, and intravaginal rings, by using its patented and proprietary technologies. AMW was founded in 2008 and is based in Warngau, Germany.

Search 177,534 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

SHS

Investor Investor Investor Investor Investor

website

Category Private Equity Firm
Founded 1993
Size Small
Type Sector Focused
DESCRIPTION

SHS is a private equity firm focused on the healthcare sector. Specific areas of interest include life science, medical technology, diagnostics, applied technologies, digital health, and industrial biotechnology. The Firm will consider opportunities at all company stages and looks to commit up to €30 million in businesses valued up to €100 million. Target geographies include Germany, Austria, Switzerland, Scandinavia, and Benelux. SHS was established in 1993 and is headquartered in Tubingen, Germany.

DEAL STATS #
Overall 12 of 26
Sector (Medical Products) 6 of 12
Type (Growth Capital) 8 of 15
Country (Germany) 9 of 17
Year (2014) 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-09-03 TRI

Hünenberg, Switzerland

TRI is a dental implants manufacturer that offers a digital portfolio and is additionally developing a Digital-Implant which integrates the dental implant connection specifically designed for CAD/CAM and 3D-printed prosthetics and thus allows for the connection of a ceramic crown directly to the implant, eliminating the need for an abutment. TRI was founded in 2010 and is based in Hünenberg, Switzerland.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-12-16 Vimecon

Alsdorf, Germany

Vimecon develops and produces laser catheters to treat heart disease with a focus on atrial fibrillation. Vimecon was founded in 2005 and is based in Alsdorf, Germany.

Buy -
Mergr

Product

Company

Legal